Author

Joachim R. Göthert

Observed name: J Göthert

Institutions: Essen University Hospital, University of Duisburg-Essen

Observed institutions: Essen University Hospital, University of Duisburg-Essen

OpenAlex ID: A5018150294

Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX)

2026 · Andreas Burchert, Franck E. Nicolini, et al. · Leukemia · 6

The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study

2026 · Harinder Gill, Abdulraheem Yacoub, et al. · Blood Advances · 1

Myelofibrosis and anemia: a German claims data analysis to describe treatment sequencing, survival outcomes, and healthcare resource utilization

2026 · Alexander Slowley, Tim d’Estrubé, et al. · Annals of Hematology

Kombinierte Gendefizienz in MDR1A und TLR2 führt zur Colitisprogression durch kommensal-induzierte Pyroptose

2013 · B Ey, A Eyking, et al. · Zeitschrift für Gastroenterologie

Works count: 4

Citation count: 7

H-index: 1

I10-index: